ClinicalTrials.gov
public full text
Public Domain
Efficacy of BNG-1 to Treat Acute Ischemic Stroke
The objective of this study is to investigate the efficacy and safety of BNG-1 in patients with ischemic stroke. The efficacy assessment will be based on the functional outcome while the safety will be reviewed by the adverse events and laboratory examinations.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke#918163
- GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases#833175
- Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke#1113938
- Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke#870129
- IMPACT- 24Bt Post Mech. Thrombectomy and/or rtPA TRIAL IMPlant Augmenting Cerebral Blood Flow 24 Hours From Stroke Onset#1173905
Record · ID 1033371
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive